Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

402 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tuberculosis treatment adherence and fatality in Spain.
Caylà JA, Rodrigo T, Ruiz-Manzano J, Caminero JA, Vidal R, García JM, Blanquer R, Casals M; Working Group on Completion of Tuberculosis Treatment in Spain (Study ECUTTE). Caylà JA, et al. Respir Res. 2009 Dec 1;10(1):121. doi: 10.1186/1465-9921-10-121. Respir Res. 2009. PMID: 19951437 Free PMC article. Clinical Trial.
A predictive scoring instrument for tuberculosis lost to follow-up outcome.
Rodrigo T, Caylà JA, Casals M, García-García JM, Caminero JA, Ruiz-Manzano J, Blanquer R, Vidal R, Altet N, Calpe JL, Penas A; Working Group on Completion of Tuberculosis Treatment in Spain. Rodrigo T, et al. Among authors: cayla ja. Respir Res. 2012 Sep 2;13(1):75. doi: 10.1186/1465-9921-13-75. Respir Res. 2012. PMID: 22938040 Free PMC article.
Resistance to first-line antituberculosis drugs in Spain, 2010-2011. RETUBES Study.
Blanquer R, Rodrigo T, Casals M, Ruiz Manzano J, García-García JM, Calpe JL, Valencia E, Pascual T, Mir I, Jiménez MÁ, Cañas F, Vidal R, Penas A, Caylà JA; Working Group of the Integrated Programme for Research in Tuberculosis in Spain. Blanquer R, et al. Among authors: cayla ja. Arch Bronconeumol. 2015 Jan;51(1):24-30. doi: 10.1016/j.arbres.2014.06.001. Epub 2014 Jul 11. Arch Bronconeumol. 2015. PMID: 25027066 English, Spanish.
Spanish Compliance With Guidelines for Prescribing Four Drugs in the Intensive Phase of Standard Tuberculosis Treatment.
García-García JM, Rodrigo T, Casals M, Ruiz-Manzano J, Pascual-Pascual T, Caylà JA; Grupo de Trabajo del Programa Integrado de Investigación en Tuberculosis (PIITB). García-García JM, et al. Among authors: cayla ja. Arch Bronconeumol. 2016 May;52(5):262-8. doi: 10.1016/j.arbres.2015.11.007. Epub 2016 Jan 28. Arch Bronconeumol. 2016. PMID: 26826890 English, Spanish.
Factors associated with smoking among tuberculosis patients in Spain.
Jiménez-Fuentes MÁ, Rodrigo T, Altet MN, Jiménez-Ruiz CA, Casals M, Penas A, Mir I, Solano Reina S, Riesco-Miranda JA, Caylá JA; Smoking and Tuberculosis Research Working Group. Jiménez-Fuentes MÁ, et al. Among authors: cayla ja. BMC Infect Dis. 2016 Sep 14;16:486. doi: 10.1186/s12879-016-1819-1. BMC Infect Dis. 2016. PMID: 27629062 Free PMC article.
Evaluation of the Integrated Tuberculosis Research Program Sponsored by the Spanish Society of Pulmonology and Thoracic Surgery: 11 Years on.
Rodrigo T, García-García JM, Caminero JA, Ruiz-Manzano J, Anibarro L, García-Clemente MM, Gullón JA, Jiménez-Fuentes MÁ, Medina JF, Mir I, Penas A, Sánchez F, Souza-Galvão ML, Caylà JA; Grupo de Trabajo del Programa Integrado de Investigación en Tuberculosis (PII-TB); Grupo de Trabajo del Programa Integrado de Investigación en Tuberculosis (PII-TB). Rodrigo T, et al. Among authors: cayla ja. Arch Bronconeumol (Engl Ed). 2020 Aug;56(8):483-492. doi: 10.1016/j.arbres.2019.10.006. Epub 2019 Nov 25. Arch Bronconeumol (Engl Ed). 2020. PMID: 31780285 English, Spanish.
Monitoring changes in anti-tuberculosis treatment: associated factors determined at the time of diagnosis.
Altet MN, Vidal R, Milá C, Rodrigo T, Casals M, Mir I, Ruiz-Manzano J, Jiménez-Fuentes MA, Sánchez F, Maldonado J, Blanquer R, de Souza-Galväo ML, Solsona J, Azlor E, Díaz D, Calpe JL, Caylá JA. Altet MN, et al. Among authors: cayla ja. Int J Tuberc Lung Dis. 2013 Nov;17(11):1435-41. doi: 10.5588/ijtld.13.0182. Int J Tuberc Lung Dis. 2013. PMID: 24125447
Factors Associated with Fatality during the Intensive Phase of Anti-Tuberculosis Treatment.
Rodrigo T, Casals M, Caminero JA, García-García JM, Jiménez-Fuentes MA, Medina JF, Millet JP, Ruiz-Manzano J, Caylá J; Working Group of the Integrated Programme of Tuberculosis Research. Rodrigo T, et al. Among authors: cayla j. PLoS One. 2016 Aug 3;11(8):e0159925. doi: 10.1371/journal.pone.0159925. eCollection 2016. PLoS One. 2016. PMID: 27487189 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 33158643
402 results